Published in J Exp Clin Cancer Res on October 26, 2015
Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity. J Exp Clin Cancer Res (2016) 0.94
For robust big data analyses: a collection of 150 important pro-metastatic genes. Chin J Cancer (2017) 0.81
Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma. J Exp Clin Cancer Res (2016) 0.77
MTA1 promotes metastasis of MPM via suppression of E-cadherin. J Exp Clin Cancer Res (2015) 0.76
Males develop faster and more severe hepatocellular carcinoma than females in kras(V12) transgenic zebrafish. Sci Rep (2017) 0.75
Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature (1998) 5.63
Biological roles and mechanistic actions of co-repressor complexes. J Cell Sci (2002) 2.86
The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis (2008) 1.92
Estrogen receptor interaction with co-activators and co-repressors. Steroids (2000) 1.91
Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology (2010) 1.68
MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology (2008) 1.60
Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett (2005) 1.44
Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin. Jpn J Cancer Res (2001) 1.41
Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. J Biol Chem (2004) 1.33
Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk. Hepatology (2003) 1.28
Estrogen receptor corepressors -- a role in human breast cancer? Endocr Relat Cancer (2003) 1.25
Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha. Hum Pathol (2004) 1.15
MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. J Biol Chem (2003) 1.15
Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway. J Biol Chem (2004) 1.12
Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology (2008) 1.07
MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b. J Exp Clin Cancer Res (2013) 1.05
Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1. Cancer Res (2014) 1.01
Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma. Int J Cancer (2014) 1.00
The role of MTA1 gene expression in human hepatocellular carcinoma. Oncol Rep (2003) 1.00
microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Mol Cancer (2015) 0.99
Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells. Nucleic Acids Res (2006) 0.98
miR-22 promotes HBV-related hepatocellular carcinoma development in males. Clin Cancer Res (2011) 0.95
Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin. J Biol Chem (2009) 0.95
MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo. J Exp Clin Cancer Res (2013) 0.93
Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection. Liver (2001) 0.91
Oestrogen attenuates tumour progression in hepatocellular carcinoma. J Pathol (2012) 0.90
The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma. Cancer (2003) 0.90
Interplay of estrogen receptors and FOXA factors in the liver cancer. Mol Cell Endocrinol (2015) 0.90
An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer. J Exp Clin Cancer Res (2014) 0.89
Estrogen suppresses metastasis in rat hepatocellular carcinoma through decreasing interleukin-6 and hepatocyte growth factor expression. Inflammation (2012) 0.89
Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. Hepatology (2012) 0.89
Better survival in women with resected hepatocellular carcinoma is not related to tumor proliferation or expression of hormone receptors. Am J Gastroenterol (1997) 0.88
ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro. J Exp Clin Cancer Res (2011) 0.88
Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine. Cancer Metastasis Rev (2014) 0.87
Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma. Dig Dis Sci (2012) 0.85
ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer. Oncotarget (2015) 0.83
Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma. Oncol Rep (2013) 0.82
Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway. Exp Biol Med (Maywood) (2015) 0.82
Estrogen receptor α (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins. J Mol Endocrinol (2013) 0.81
Female sex hormone receptor status in advanced hepatocellular carcinoma and outcome after surgical resection. Surgery (1997) 0.81
SpliceArray profiling of breast cancer reveals a novel variant of NCOR2/SMRT that is associated with tamoxifen resistance and control of ERα transcriptional activity. Cancer Res (2012) 0.81
Aberrant estrogen receptor alpha expression correlates with hepatocellular carcinoma metastasis and its mechanisms. Hepatogastroenterology (2014) 0.79
ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer. J Exp Clin Cancer Res (2015) 0.78
Clinicopathologic comparisons between estrogen receptor-positive and -negative hepatocellular carcinomas. Ann Surg (1990) 0.78
The transcriptional co-repressor TLE3 suppresses basal signaling on a subset of estrogen receptor α target genes. Nucleic Acids Res (2014) 0.78